|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Amortization of prior hedge effectiveness | |||||
| Amortization of right-of-use assets | |||||
| Stock-based compensation | |||||
| Impairment of long-lived assets | |||||
| Impairment of other equity security | |||||
| Loss on debt extinguishment | |||||
| Discontinuance of interest rate swaps and write-off of prior hedge effectiveness | |||||
| Gain on sale of assets held for sale | |||||
| Change in fair value of other equity security | |||||
| Gain on sale of available-for-sale debt security | |||||
| Deferred income taxes | |||||
| Change in fair value of contingent consideration | |||||
| Change in fair value of financial guarantee | |||||
| Change in fair value of derivative instruments | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Non-cash interest expense | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of effects of business combination: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Income tax payable | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisitions, net of cash acquired | |||||
| Asset acquisition, net of cash acquired | |||||
| Proceeds from acquisition working capital adjustment | |||||
| Purchase of property and equipment | |||||
| Payment upon extinguishment of interest rate swaps | |||||
| Purchase of other equity security | |||||
| Proceeds from sale of available-for-sale debt securities | |||||
| Proceeds from sale of assets held for sale | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Repayment of finance lease obligations | |||||
| Payment of contingent consideration | |||||
| Payment of debt issuance costs | |||||
| Repayment of 2018 Term Loan | |||||
| Repayment of hybrid debt | |||||
| Payment upon extinguishment of hybrid debt | |||||
| Repurchase of common stock | |||||
| Payment of special dividends | |||||
| Proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions | |||||
| Proceeds from private placement, net of underwriting discounts and commissions | |||||
| Payment of share repurchase excise taxes and repurchase costs | |||||
| Shares surrendered for settlement of minimum statutory tax withholding | |||||
| Proceeds from issuance of stock under employee stock plans | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of the period | |||||
| Cash and cash equivalents, at end of the period | |||||
| Interest | |||||
| Income taxes | |||||
| Reconciliation of cash and cash equivalents in the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Non-cash operating, investing, and financing activities: | |||||
| Right of use assets obtained in exchange of operating lease liabilities (excluding right-of-use assets acquired as part of business acquisition) | |||||
| Capitalized stock-based compensation | |||||
| Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities | |||||
| Conversion of Series A redeemable convertible preferred stock into common stock in connection with initial public offering | |||||
| Change in fair value of hedged interest rate swaps and interest rate cap | |||||
| Issuance of common stock for acquisition consideration | |||||
| Accrued stock repurchase excise tax | |||||
| Acquisition related deferred consideration | |||||
Loading...